United Kingdom · 
Who invested in Osler Diagnostics?
Osler Diagnostics's investors include Oxford Science Enterprises.
2023
$85MSeries C$5.4MSeries C
United Kingdom · Series C startup
Who invested in Osler Diagnostics
Funding summaryUpdated 26 Oct 2026
$90Mraised across 2 rounds since 2022, from 2 sources
$85MSeries C$5.4MSeries C
- Latest round
- Series C, $5.4MFeb 2023
- Biggest round
- $85MSeries C · Nov 2022
- Investors
- 1
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series C, $85M Nov 2022
- Biggest round
- $85M Series C · Nov 2022
- Between rounds
- 3 months from the last two
The rounds
- Feb 2023Series C$5.4M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
- Nov 2022
Funding filed with regulators
Osler Diagnostics filed 2 raises, $87M in all. Filings say how much was sold and to how many investors; they never name the investors.
- Feb 2023$5.4MUK share allotment
- Nov 2022$81MUK share allotment
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Osler Diagnostics
How much has Osler Diagnostics raised?
Osler Diagnostics has raised $90M across 2 rounds since 2022.
When did Osler Diagnostics last raise?
Osler Diagnostics's most recent round was a Series C of $5.4M in Feb 2023.
What was Osler Diagnostics's biggest round?
Osler Diagnostics's largest round on record is $85M (Series C), in Nov 2022.
Who backed Osler Diagnostics first?
Osler Diagnostics's first round on record, in Nov 2022, was backed by Oxford Science Enterprises.
What stage is Osler Diagnostics at?
Osler Diagnostics's latest named round is a Series C, in Feb 2023.
Where is Osler Diagnostics based?
Osler Diagnostics is based in the United Kingdom.
Companies like Osler Diagnostics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.